Trade Summary

1 week ago, Devinney Erick Wayne, serving as Chief Innovation Officer at Axogen, Inc. (AXGN), sold 5,221 shares at $32.84 per share, for a total transaction value of $171,458.00. Following this transaction, Devinney Erick Wayne now holds 262,781 shares of AXGN.

This sale represents a 2.00% decrease in Devinney Erick Wayne's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, March 16, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 18, 2026, 2 days after the trade was made.

Axogen, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.